Bharat Biotech Says Its ICMR-Backed Coronavirus Vaccine Named Covaxin Ready for June 2021 Launch - Coronavirus Updates

The Drugs Controller General of India DCGI had on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions.

Read More >>